These data suggest that Trp53 mutations arose in individual tumor cells in mice of both Brm-positive and Brm-negative phenotypes, but that in the Brm-positive tumor cells, the clones of more dysfunctional Trp53 mutations became more ubiquitous (positive selection) within a given Brm-positive tumor. Here, TP53 is linked to neoplasm.